What treatments are available for someone who has CPRC and the ARPI stopped working

Treatment Options for Castration-Resistant Prostate Cancer (CRPC) After ARPI Failure

I understand this is a challenging situation. When an androgen receptor pathway inhibitor (ARPI) like enzalutamide or abiraterone stops working, there are still several evidence-based treatment options available.

Current Treatment Approaches

According to NCCN Guidelines for Prostate Cancer, when an ARPI becomes ineffective, your oncologist may consider:

1. Switch to a Different ARPI

• If you were on enzalutamide, switching to abiraterone (or vice versa) can sometimes be effective
• These drugs work through slightly different mechanisms, so one may work when another doesn't

2. Chemotherapy

• Docetaxel is a standard option recommended by ASCO Guidelines
• Cabazitaxel is another chemotherapy option, particularly if docetaxel was used previously
• These are FDA-approved for metastatic CRPC

3. Immunotherapy

• Sipuleucel-T (Provenge) - an FDA-approved cancer vaccine for certain CRPC patients
• The American Cancer Society notes this may be considered depending on your specific situation

4. Targeted Therapies

• PARP inhibitors (like olaparib or rucaparib) if you have specific genetic mutations (BRCA1/2, etc.)
• Radium-223 if cancer has spread to bones - this is an FDA-approved radiotherapy option

5. Clinical Trials

• The NCI maintains a database of active trials testing newer combinations and approaches

Important Next Steps

Talk with your oncologist about:

• Whether genetic testing has been done (crucial for PARP inhibitor eligibility)
• Your overall health and ability to tolerate different treatments
• Whether your cancer has spread and where
• Combination approaches that might be appropriate

Would you like me to explain any of these options in more detail?